Catalent Forms Strategic Alliance with PAREXEL


Oct 05, 2012


Catalent Pharma announced a global alliance with PAREXEL International to help streamline the clinical trial supply process. The result of years of collaboration, the alliance will provide a seamless, fully integrated service offering to ensure the timely and efficient delivery of clinical trial materials.

 "As clinical trials become more complex, we feel it is imperative to help sponsors devise supply strategies and organize consistent manufacturing, packaging, and delivery of trial-related supplies to locations around the world," stated Gerry Hepburn, Chief Operating Officer, Vice President and General Manager of Clinical Supply Services at Catalent. "PAREXEL, with its extensive and unparalleled track record in clinical development, is the ideal partner for Catalent in this alliance, which will enable our customers to compete more effectively in the global marketplace."

 "One of the most important steps in creating a strong, efficient clinical trial material supply chain is selecting a partner with innovative clinical packaging solutions and established global operations to oversee and coordinate all aspects of each critical supply chain stage," commented Kurt Norris, Corporate Vice President, Clinical Logistics Services, PAREXEL. "In establishing this alliance with Catalent, we have chosen a partner that is uniquely positioned to help biopharmaceutical companies reach critical development milestones through more efficient delivery of clinical trial supplies."

The alliance will provide fully integrated services and technologies across the entire clinical trial material supply chain spectrum, supporting all supply aspects in clinical development programs including: planning and development of supply strategies; material supply and demand forecasting; central and local clinical trial and ancillary material sourcing; innovative clinical manufacturing and leading clinical trial packaging solutions; worldwide regulatory and import/export management; global and local storage as well as distribution to trial sites; depot, site and patient inventory management; and material return and destruction/disposition.